Cargando…

QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery

Virtual screening (VS) has emerged in drug discovery as a powerful computational approach to screen large libraries of small molecules for new hits with desired properties that can then be tested experimentally. Similar to other computational approaches, VS intention is not to replace in vitro or in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Neves, Bruno J., Braga, Rodolpho C., Melo-Filho, Cleber C., Moreira-Filho, José Teófilo, Muratov, Eugene N., Andrade, Carolina Horta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262347/ https://www.ncbi.nlm.nih.gov/pubmed/30524275 http://dx.doi.org/10.3389/fphar.2018.01275

Ejemplares similares

QSAR-Driven Design and Discovery of Novel Compounds With Antiplasmodial and Transmission Blocking Activities
por: Lima, Marilia N. N., et al.
Publicado: (2018)

QSAR-Based Virtual Screening of Natural Products Database for Identification of Potent Antimalarial Hits
por: Ferreira, Letícia Tiburcio, et al.
Publicado: (2021)

Discovery of new Schistosoma mansoni aspartyl protease inhibitors by structure-based virtual screening
por: Gomes, Bárbara Figueira, et al.
Publicado: (2023)

Deep Learning-driven research for drug discovery: Tackling Malaria
por: Neves, Bruno J., et al.
Publicado: (2020)

Virtual Screening and Molecular Design Based on Hierarchical Qsar Technology
por: Kuz’min, Victor E., et al.
Publicado: (2009)

In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery
por: de Souza Neto, Lauro Ribeiro, et al.
Publicado: (2020)

Drug Design for CNS Diseases: Polypharmacological Profiling of Compounds Using Cheminformatic, 3D-QSAR and Virtual Screening Methodologies
por: Nikolic, Katarina, et al.
Publicado: (2016)

Small Molecule Antiviral Compound Collection (SMACC): a database to support the discovery of broad-spectrum antiviral drug molecules
por: Martin, Holli-Joi, et al.
Publicado: (2022)

Evaluation of QSAR Equations for Virtual Screening
por: Spiegel, Jacob, et al.
Publicado: (2020)

QSAR Modeling for Multi-Target Drug Discovery: Designing Simultaneous Inhibitors of Proteins in Diverse Pathogenic Parasites
por: Kleandrova, Valeria V., et al.
Publicado: (2021)

Discovery of Novel HPK1 Inhibitors Through Structure-Based Virtual Screening
por: Ge, Huizhen, et al.
Publicado: (2022)

Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products
por: Du, Yue, et al.
Publicado: (2022)

Transfer and Multi-task Learning in QSAR Modeling: Advances and Challenges
por: Simões, Rodolfo S., et al.
Publicado: (2018)

Discovery of Novel IDH1 Inhibitor Through Comparative Structure-Based Virtual Screening
por: Wang, Yuwei, et al.
Publicado: (2020)

Déjà vu: Stimulating open drug discovery for SARS-CoV-2
por: Ekins, Sean, et al.
Publicado: (2020)

Predicting chemically-induced skin reactions. Part II: QSAR models of skin permeability and the relationships between skin permeability and skin sensitization
por: Alves, Vinicius M., et al.
Publicado: (2015)

Discovery of Novel Inhibitors of Indoleamine 2,3-Dioxygenase 1 Through Structure-Based Virtual Screening
por: Zhang, Guoqing, et al.
Publicado: (2018)

Discovery of novel IDH1-R132C inhibitors through structure-based virtual screening
por: Hu, Chujiao, et al.
Publicado: (2022)

Chapter 9 Molecular Similarity: Advances in Methods, Applications and Validations in Virtual Screening and QSAR
por: Bender, Andreas, et al.
Publicado: (2006)

Discovery of Potent Disheveled/Dvl Inhibitors Using Virtual Screening Optimized With NMR-Based Docking Performance Index
por: Hori, Kiminori, et al.
Publicado: (2018)

Discovery of potent and noncovalent KRAS(G12D) inhibitors: Structure-based virtual screening and biological evaluation
por: Wang, Yuting, et al.
Publicado: (2022)

Computational models identify several FDA approved or experimental drugs as putative agents against SARS-CoV-2
por: Bobrowski, Tesia, et al.
Publicado: (2020)

Discovery of new TLR7 agonists by a combination of statistical learning-based QSAR, virtual screening, and molecular dynamics
por: Abiri, Ardavan, et al.
Publicado: (2021)

Development of QSAR models to predict blood-brain barrier permeability
por: Faramarzi, Sadegh, et al.
Publicado: (2022)

Computationally-guided drug repurposing enables the discovery of kinase targets and inhibitors as new schistosomicidal agents
por: Giuliani, Sandra, et al.
Publicado: (2018)

Simplex representation of molecular structure as universal QSAR/QSPR tool
por: Kuz’min, Victor, et al.
Publicado: (2021)

Computational Identification of Inhibitors Using QSAR Approach Against Nipah Virus
por: Rajput, Akanksha, et al.
Publicado: (2019)

QSAR-Assisted Virtual Screening of Lead-Like Molecules from Marine and Microbial Natural Sources for Antitumor and Antibiotic Drug Discovery
por: Pereira, Florbela, et al.
Publicado: (2015)

The A–Z of Zika drug discovery
por: Mottin, Melina, et al.
Publicado: (2018)

Integrating Machine Learning-Based Virtual Screening With Multiple Protein Structures and Bio-Assay Evaluation for Discovery of Novel GSK3β Inhibitors
por: Zhu, Jingyu, et al.
Publicado: (2020)

Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis
por: Liu, Jiawei, et al.
Publicado: (2022)

Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
por: Ganji, Mahmoud, et al.
Publicado: (2023)

In Silico Rational Design and Virtual Screening of Bioactive Peptides Based on QSAR Modeling
por: Mahmoodi-Reihani, Mehri, et al.
Publicado: (2020)

In Silico Repositioning-Chemogenomics Strategy Identifies New Drugs with Potential Activity against Multiple Life Stages of Schistosoma mansoni
por: Neves, Bruno J., et al.
Publicado: (2015)

STopTox: An in Silico Alternative to Animal Testing for Acute Systemic and Topical Toxicity
por: Borba, Joyce V.B., et al.
Publicado: (2022)

Conserved coronavirus proteins as targets of broad-spectrum antivirals
por: Melo-Filho, Cleber C., et al.
Publicado: (2022)

Combining QSAR Modeling and Text-Mining Techniques to Link Chemical Structures and Carcinogenic Modes of Action
por: Papamokos, George, et al.
Publicado: (2016)

3D-QSAR, Molecular Docking, and MD Simulations of Anthraquinone Derivatives as PGAM1 Inhibitors
por: Wang, Yuwei, et al.
Publicado: (2021)

QSAR and molecular docking studies on designing potent inhibitors of SARS-CoVs main protease
por: Song, Fucheng, et al.
Publicado: (2023)

DPubChem: a web tool for QSAR modeling and high-throughput virtual screening
por: Soufan, Othman, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vi9f19juhajnbpfnvfbomnt9mo